Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
基石藥業獲首席執行官購入56萬股 持股升至5.46%

2025-04-09T  
基石藥業折讓近15%配股 淨籌2.32億元

2025-04-02T  
《業績》基石藥業去年虧損收窄至9,120.7萬人幣

2025-03-27T  
基石藥業:5款藥物臨床前研究成果將於美國AACR年會公布

2025-03-26T  
基石藥業:已向歐洲藥品局提交舒格利單抗新適應症申請

2025-03-24T  
基石藥業向澳洲遞交治療淋巴瘤藥物臨床試驗申請

2025-03-06T  
基石藥業治療實體瘤藥物臨床試驗順利完成首例患者給藥

2025-03-04T  
基石藥業擇捷美GEMSTONE-303發布研究數據

2025-02-25T  
基石藥業舒格利單抗藥物獲納入歐洲腫瘤內科學會指南

2025-02-10T  
基石藥業-B與SteinCares達成商業化戰略合作

2025-01-27T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.